福泰製藥公司
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionJefferies Group LLC
Latest Disclosed Ownership1,447 shares
Latest Disclosed Value $ 418,964
Jefferies Group LLC ownership in VRTX / Vertex Pharmaceuticals Incorporated

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 1,447 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $418,964 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 1,116 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 29.66% during the quarter. The current value of the position is $646,563 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 5,200 of underlying shares valued at $1,505,608 USD and put options representing 200 of underlying shares valued at $57,908 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,447 331 29.66 419 33.12 0.0035
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,877 -2,559 423 0.0034
2023-09-21 2022-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,116 366 48.80 314 61.03 0.0026
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,436 3,686 336 0.0026
2023-09-21 2022-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 750 -4,125 -84.62 196 -81.78 0.0012
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,210 -534 241 0.0014
2023-09-21 2021-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 4,875 -20,191 -80.55 1,071 -76.46 0.0063
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,744 -19,322 1,159 0.0062
2023-09-21 2021-09-30 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 25,066 8,427 50.65 4,547 35.54 0.0331
2021-12-17 2021-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 25,066 8,427 4,547 0.0312
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 25,066 8,427 4,547 0.0293
2023-09-21 2021-06-30 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 16,639 6,945 71.64 3,355 61.02 0.0211
2021-08-20 2021-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 16,639 6,945 3,355 0.0199
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 16,639 6,945 3,355 0.0199
2023-09-21 2021-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 9,694 8,772 951.41 2,083 859.91 0.0183
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 9,694 8,772 2,083 0.0182
2023-09-21 2020-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 922 158 20.68 218 4.33 0.0017
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 922 158 218 0.0020
2020-11-13 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 764 764 208 0.0023
2020-11-02 2020-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 0 -966 -100.00 0 -100.00
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 966 -16,614 -94.51 230 -94.02 0.0029
2020-02-13 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17,580 -20,944 -54.37 3,849 -41.03 0.0298
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 38,524 23,646 158.93 6,527 139.26 0.0506
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 14,878 9,385 170.85 2,728 170.10 0.0199
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,493 3,024 122.48 1,010 146.94 0.0083
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,469 -1,217 -33.02 409 -42.39 0.0033
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,686 -38,586 -91.28 710 -90.12 0.0046
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 42,272 13,178 45.29 7,185 51.52 0.0402
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 29,094 28,940 18,792.21 4,742 20,517.39 0.0255
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 154 -34,146 -99.55 23 -99.56 0.0001
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 34,300 -3,089 -8.26 5,215 8.24 0.0344
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 37,389 -49,606 -57.02 4,818 -49.35 0.0321
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 86,995 70,587 430.20 9,513 686.85 0.0708
2017-02-14 2016-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 16,408 1,039 6.76 1,209 -9.78 0.0068
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 16,408 1,209
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 15,369 15,369 0.00 1,340 0.0069
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -29,613 -100.00 0 -100.00
2016-05-11 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 29,613 23,835 412.51 2,354 223.80 0.0135
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,778 -30,424 -84.04 727 -80.72 0.0041
2015-11-13 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 36,202 36,052 24,034.67 3,771 19,747.37 0.0216
2015-08-18 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 150 0 0.00 19 5.56 0.0001
2015-05-18 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 150 -129,367 -99.88 18 -99.88 0.0001
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 129,517 127,271 5,666.56 15,387 6,005.95 0.0903
2014-11-17 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,246 -14,038 -86.21 252 -83.66 0.0017
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 16,284 -16,353 -50.11 1,542 -33.19 0.0130
2014-05-16 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 32,637 29,574 965.52 2,308 916.74 0.0224
2014-02-18 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,063 3,063 -71.53 227 -73.64 0.0014
2013-11-18 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -10,758 -100.00 0 -100.00
2013-08-15 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,758 10,758 861 0.0092
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A VERTEX PHARMACEUTICALS COM Call 5,200 0.00 1,506 2.73 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 5,200 1,506 n/a n/a n/a
2023-09-21 2022-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 5,200 -63.89 1,465 -61.01 n/a n/a n/a
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM Call 5,200 1,465 n/a n/a n/a
2023-09-21 2022-03-31 13F/A VERTEX PHARMACEUTICALS COM Call 14,400 -82.00 3,758 -78.61 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Call 14,400 3,758 n/a n/a n/a
2023-09-21 2021-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 80,000 33.33 17,568 61.43 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Call 80,000 17,568 n/a n/a n/a
2021-12-17 2021-09-30 13F/A VERTEX PHARMACEUTICALS COM Call 60,000 10,883 n/a n/a n/a
2023-09-21 2021-09-30 13F/A VERTEX PHARMACEUTICALS COM Call 60,000 10,883 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Call 60,000 10,883 n/a n/a n/a
2021-08-20 2021-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2023-09-21 2021-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-09-21 2021-03-31 13F/A VERTEX PHARMACEUTICALS COM Call 3,000 -40.00 645 -45.47 n/a n/a n/a
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS COM Call 3,000 645 n/a n/a n/a
2023-09-21 2020-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 5,000 1,182 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Call 5,000 1,182 n/a n/a n/a
2020-11-02 2020-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Call 15,100 128.79 3,593 148.65 n/a n/a n/a
2020-02-13 2019-12-31 13F VERTEX PHARMACEUTICALS COM Call 6,600 842.86 1,445 1,114.29 n/a n/a n/a
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS COM Call 700 119 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM Call 26,400 4,375 n/a n/a n/a
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM Call 3,900 -77.71 584 -78.05 n/a n/a n/a
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM Call 17,500 -29.44 2,661 -16.74 n/a n/a n/a
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM Call 24,800 16.98 3,196 37.88 n/a n/a n/a
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM Call 21,200 2,318 n/a n/a n/a
2016-05-11 2016-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2015-11-13 2015-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-18 2015-06-30 13F VERTEX PHARMACEUTICALS COM Call 16,900 -51.71 2,087 -49.46 n/a n/a n/a
2015-05-18 2015-03-31 13F VERTEX PHARMACEUTICALS COM Call 35,000 -68.18 4,129 -68.40 n/a n/a n/a
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM Call 110,000 13,068 n/a n/a n/a
2014-11-17 2014-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM Call 49,700 151.01 4,706 236.14 n/a n/a n/a
2014-05-16 2014-03-31 13F VERTEX PHARMACEUTICALS COM Call 19,800 -19.18 1,400 -23.08 n/a n/a n/a
2014-02-18 2013-12-31 13F VERTEX PHARMACEUTICALS COM Call 24,500 1,820 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A VERTEX PHARMACEUTICALS COM Put 200 0.00 58 1.79 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Put 200 58 n/a n/a n/a
2023-09-21 2022-06-30 13F/A VERTEX PHARMACEUTICALS COM Put 200 56 n/a n/a n/a
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM Put 200 56 n/a n/a n/a
2023-09-21 2022-03-31 13F/A VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2023-09-21 2021-12-31 13F/A VERTEX PHARMACEUTICALS COM Put 85,000 0.00 18,666 21.07 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Put 85,000 18,666 n/a n/a n/a
2021-12-17 2021-09-30 13F/A VERTEX PHARMACEUTICALS COM Put 85,000 15,418 n/a n/a n/a
2023-09-21 2021-09-30 13F/A VERTEX PHARMACEUTICALS COM Put 85,000 240.00 15,418 205.91 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Put 85,000 15,418 n/a n/a n/a
2021-08-20 2021-06-30 13F/A VERTEX PHARMACEUTICALS COM Put 25,000 5,041 n/a n/a n/a
2023-09-21 2021-06-30 13F/A VERTEX PHARMACEUTICALS COM Put 25,000 0.00 5,041 -6.18 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Put 2,500,000 5,041 n/a n/a n/a
2023-09-21 2021-03-31 13F/A VERTEX PHARMACEUTICALS COM Put 25,000 5,372 n/a n/a n/a
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS COM Put 25,000 5,372 n/a n/a n/a
2020-11-02 2020-06-30 13F/A VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Put 11,700 -63.32 2,784 -60.14 n/a n/a n/a
2020-02-13 2019-12-31 13F VERTEX PHARMACEUTICALS COM Put 31,900 -40.82 6,985 -23.51 n/a n/a n/a
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS COM Put 53,900 9,132 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM Put 80,700 13,373 n/a n/a n/a
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM Put 140,000 23,794 n/a n/a n/a
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM Put 189,200 20,689 n/a n/a n/a
2016-05-11 2016-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM Put 61,000 388.00 7,676 489.55 n/a n/a n/a
2015-11-13 2015-09-30 13F VERTEX PHARMACEUTICALS COM Put 12,500 443.48 1,302 358.45 n/a n/a n/a
2015-08-18 2015-06-30 13F VERTEX PHARMACEUTICALS COM Put 2,300 284 n/a n/a n/a
2015-05-18 2015-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM Put 221,400 98.74 26,302 110.23 n/a n/a n/a
2014-11-17 2014-09-30 13F VERTEX PHARMACEUTICALS COM Put 111,400 -25.39 12,511 -11.50 n/a n/a n/a
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM Put 149,300 69.47 14,136 126.90 n/a n/a n/a
2014-05-16 2014-03-31 13F VERTEX PHARMACEUTICALS COM Put 88,100 -25.84 6,230 -29.42 n/a n/a n/a
2014-02-18 2013-12-31 13F VERTEX PHARMACEUTICALS COM Put 118,800 142.94 8,827 125.47 n/a n/a n/a
2013-11-18 2013-09-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-08-15 2013-06-30 13F VERTEX PHARMACEUTICALS COM Put 48,900 3,915 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.